What they were paid
Akebia Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $70,000 | $139,944 | $182,582 | $0 | $392,526 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Akebia Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001517022-26-000034, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Akebia Therapeutics pays directors a $50,000 cash retainer and $322,526 in RSUs.
Committees
FY2025 · as the proxy prints themAudit (Chair)
The rest of the Akebia Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Adrian Adams | Chair of the Board | $415,026 |
| Cynthia Smith | Independent Director | $392,526 |
| John P. Butler | Director | $0 |
| LeAnne M. Zumwalt | Independent Director | $387,526 |
| Myles Wolf | Independent Director | — |
| Philip J. Vickers | Independent Director | $0 |
| Ronald E. Frieson | Independent Director | $392,526 |
The full Akebia Therapeutics compensation record
free company briefThis page is one director within Akebia Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat